Discover how to prevent pancreatic cancer early

Researchers at the Peggy and Charles Stephenson Oklahoma Cancer Center in the US have discovered a way to prevent pancreatic cancer in the early stages - a finding that has important implications for cancer prevention in High-risk patients.

The results of this study are published in the American Cancer Research Association's Cancer Prevention Research .

In their experiments, Dr. CV Rao and colleagues discovered that the use of low doses of Gefitinib, without causing side effects at this level, helped prevent the development of Pancreatic tumors . Moreover, after 41 weeks of treatment, this dangerous disease also disappeared.

According to scientists, the drug Gefitinib works by identifying the signals of a gene that is among the first mutated genes when pancreatic cancer is present.

By identifying signals for tumor growth through mutated genes, scientists can prevent the development of the disease.

Dr. Rao said: " This is one of the most important studies in pancreatic cancer prevention. So far we have not had a clear understanding of the disease and treatment is only conducted. "When we detect the disease in the late stages. But we found that if started early, the treatment will get bigger results. Our goal is to prevent the spread of the disease ."

Pancreatic cancer is a common cancer in the digestive tract, it accounts for about 10% of gastrointestinal cancer and about 2% of all cancers. The disease is more common in men than in women, usually after age 60, with risk factors such as tobacco, alcohol, coffee, meat, fat, diabetes .

In general, pancreatic cancer is a type of cancer that is difficult to diagnose, so it is often diagnosed late, so prognosis is often difficult.

Pancreatic cancer includes exocrine pancreatic cancer - a common type and endocrine pancreatic cancer - this is less common.